SUPERNUS PHARMACEUTICALS, INC. (SUPN) Revenue 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$719.0MFY2025 · since FY2016: $215.0M → $719.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $719.0M | +8.6% |
| FY2024 | $661.8M | +8.9% |
| FY2023 | $607.5M | -8.9% |
| FY2022 | $667.2M | +15.1% |
| FY2021 | $579.8M | +11.4% |
| FY2020 | $520.4M | +32.5% |
| FY2019 | $392.8M | -3.9% |
| FY2018 | $408.9M | +35.3% |
| FY2017 | $302.2M | +40.6% |
| FY2016 | $215.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice